Progenra and Ono Pharmaceutical will partner to develop assays and conduct high throughput screening of undisclosed ubiquitin pathway targets using Progenra's UbiPro drug discovery platform

Progenra Inc.

U.S. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Ono Pharmaceutical Co. Ltd.

Japan / Mid-Cap Biopharma ($1-$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced